Stock DNA
Pharmaceuticals & Biotechnology
CNY 17,116 Million (Large Cap)
111.00
NA
0.00%
-0.37
10.38%
8.98
Revenue and Profits:
Net Sales:
388 Million
(Quarterly Results - Sep 2025)
Net Profit:
84 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
96.07%
0%
96.07%
6 Months
69.91%
0%
69.91%
1 Year
23.34%
0%
23.34%
2 Years
147.71%
0%
147.71%
3 Years
430.97%
0%
430.97%
4 Years
450.5%
0%
450.5%
5 Years
627.51%
0%
627.51%
Inner Mongolia Furui Medical Science Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.09%
EBIT Growth (5y)
18.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.75
Tax Ratio
27.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.67%
ROE (avg)
9.89%
Valuation key factors
Factor
Value
P/E Ratio
111
Industry P/E
Price to Book Value
9.87
EV to EBIT
62.70
EV to EBITDA
46.15
EV to Capital Employed
14.76
EV to Sales
12.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.55%
ROE (Latest)
8.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
387.60
337.20
14.95%
Operating Profit (PBDIT) excl Other Income
109.30
84.30
29.66%
Interest
0.80
0.60
33.33%
Exceptional Items
1.20
0.00
Consolidate Net Profit
84.00
47.40
77.22%
Operating Profit Margin (Excl OI)
281.90%
178.80%
10.31%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 14.95% vs 19.36% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 77.22% vs 8.72% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,340.90
1,143.20
17.29%
Operating Profit (PBDIT) excl Other Income
379.90
335.10
13.37%
Interest
3.00
1.40
114.29%
Exceptional Items
-7.70
0.00
Consolidate Net Profit
195.90
177.10
10.62%
Operating Profit Margin (Excl OI)
212.40%
214.20%
-0.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 17.29% vs 14.56% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 10.62% vs 21.80% in Dec 2023
About Inner Mongolia Furui Medical Science Co., Ltd. 
Inner Mongolia Furui Medical Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






